NEO
NeoGenomics, Inc.
17.95
USD
This page is just a preview of the data found in TrendSpider’s full version
NeoGenomics, Inc. stock is up 7.29% since 30 days ago. The next earnings date is Feb 22, 2024. The company has had below-average volume in the last 30 days. Its seasonality going into this month shows a chance of a red month, as 27.27% of the previous 11 December’s closed higher than November. In the last 9 Unusual Options Trades, there were 2 PUTs, 7 CALLs. 0% of analysts rate it a buy.
| Date & Time | Expiration Date | Strike Price | Trade Type | Size | Open Interest |
|---|---|---|---|---|---|
| 18 Oct 15:27 | 17 May, 2024 | 20.00 | 0 | ||
| 20 Oct 17:23 | 17 Nov, 2023 | 17.50 | 329 | ||
| 23 Oct 17:19 | 17 Nov, 2023 | 5.00 | 240 | ||
| 03 Nov 15:04 | 17 Nov, 2023 | 10.00 | 44 | ||
| 27 Nov 15:52 | 17 May, 2024 | 20.00 | 369 | ||
| 27 Nov 17:24 | 17 May, 2024 | 15.00 | 13 | ||
| 28 Nov 14:30 | 17 May, 2024 | 15.00 | 984 | ||
| 28 Nov 14:40 | 17 May, 2024 | 15.00 | 984 | ||
| 28 Nov 17:35 | 16 Feb, 2024 | 17.50 | 262 |
NeoGenomics, Inc. operates a network of cancer-focused testing laboratories in the United States, Europe, and Asia. The company offers testing services to hospitals, reference labs, pathologists, oncologists, clinicians, pharmaceutical firms, and researchers. It has a strategic alliance agreement and laboratory services agreement with Inivata Limited.
